Relapsed classic Hodgkin lymphoma with decreased CD30 expression after brentuximab and anti-CD30 CAR-T therapies

Do Hwan Kim; Francisco Vega

doi:10.1182/blood.2021013881

Relapsed classic Hodgkin lymphoma with decreased CD30 expression after brentuximab and anti-CD30 CAR-T therapies

Do Hwan Kim, Francisco Vega

Hematopathology

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Original language	English (US)
Pages (from-to)	951
Number of pages	1
Journal	Blood
Volume	139
Issue number	6
DOIs	https://doi.org/10.1182/blood.2021013881
State	Published - Feb 10 2022

ASJC Scopus subject areas

Biochemistry
Immunology
Hematology
Cell Biology

Access to Document

10.1182/blood.2021013881

Cite this

@article{f31c79f2d2144afd855f6d221248b5de,

title = "Relapsed classic Hodgkin lymphoma with decreased CD30 expression after brentuximab and anti-CD30 CAR-T therapies",

author = "Kim, {Do Hwan} and Francisco Vega",

year = "2022",

month = feb,

day = "10",

doi = "10.1182/blood.2021013881",

language = "English (US)",

volume = "139",

pages = "951",

journal = "Blood",

issn = "0006-4971",

publisher = "American Society of Hematology",

number = "6",

}

TY - JOUR

T1 - Relapsed classic Hodgkin lymphoma with decreased CD30 expression after brentuximab and anti-CD30 CAR-T therapies

AU - Kim, Do Hwan

AU - Vega, Francisco

PY - 2022/2/10

Y1 - 2022/2/10

UR - http://www.scopus.com/inward/record.url?scp=85124498553&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124498553&partnerID=8YFLogxK

U2 - 10.1182/blood.2021013881

DO - 10.1182/blood.2021013881

M3 - Article

C2 - 35142847

AN - SCOPUS:85124498553

SN - 0006-4971

VL - 139

SP - 951

JO - Blood

JF - Blood

IS - 6

ER -

Relapsed classic Hodgkin lymphoma with decreased CD30 expression after brentuximab and anti-CD30 CAR-T therapies

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this